10/10/2025
3:41 PM | Athira Pharma (Subject)
Oliveira Steven Michael (Filed by)
| Form SCHEDULE 13G/A | |
10/03/2025
8:11 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2025
8:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2025
3:32 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:33 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
3:33 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
6:33 PM | Athira Pharma (Subject)
Worthington Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
6:34 PM | Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
6:36 PM | Athira Pharma (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025
6:37 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025
4:32 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ATHA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. |
06/03/2025
4:33 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
4:34 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
4:34 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
4:35 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
4:36 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
4:37 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
3:15 PM | Athira Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/16/2025
3:22 PM | Athira Pharma (Subject)
Oliveira Steven Michael (Filed by)
| Form SCHEDULE 13G | |
03/12/2025
4:20 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4/A | |
03/04/2025
3:28 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:29 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:29 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:30 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:10 PM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
9:21 AM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:59 AM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/02/2025
7:02 PM | Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:04 PM | Athira Pharma (Subject)
Worthington Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:05 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:06 PM | Athira Pharma (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
12:15 PM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
3:16 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024
11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024
5:24 AM | Athira Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
